Latest Insights on DNA
Last Call For Inflation Fears; You, Me & Genetic Privacy July 13, 2021 Great Stuff The Last, Last Word On Inflation (For Real This Time) Sup, Great Ones! How are you lot today? Everything all right at home? In your portfolios? Anything you want to get off your chest and into our inbox for Reader Feedback? Just checking in on y’all before we dive into the meat of the matter […]
Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance June 28, 2021 Great Stuff Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]
Genes Get Wilder: 23andMe, You & Big Brother June 19, 2021 Great Stuff What’s The Deal With 23andMe? Great Ones, what do you know about 23andMe (Nasdaq: )? Some of you probably know 23andMe from its home testing kits. No, not home drug tests — genetic tests that tell you where your ancestors came from. 23andMe’s tests were a popular holiday/birthday gift a few years ago. According to […]
Nvidia ARM Wrestles U.K., AMD Scores With Google & Trade Desk Decimated June 18, 2021 Great Stuff Friday Four Play: The “AnARMchy In The U.K.” Edition Great Ones, have you checked in on your Nvidia (Nasdaq: ) position lately? What Nvidia position? You know, the one I recommended not three weeks ago in Great Stuff’s weekend edition: “What’s The Deal With Nvidia?” I made it an official Great Stuff Picks recommendation too. […]
New Biotech SPACs Could Help Spark a Rally June 8, 2021 Investment Opportunities, Technology, Winning Investor Daily One venture capitalist’s decision to specifically target biotech companies suggests the industry presents the highest return potential.





